Abstract
In routine clinical practice 20% of patients with pulmonary tuberculosis were treated with the regimen recommended by the British Thoracic Association after the British trial of short-course chemotherapy. Despite the use of several regimens that could be considered inadequate, no patients from the survey within south and west Wales appears to have relapsed yet. Deaths from pulmonary tuberculosis continue at the same rate as 10 years ago. Patient default remains a difficult problem even with modern, less toxic, short-course regimens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fox W., Mitchison D. A. Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis. 1975 Mar;111(3):325–353. doi: 10.1164/arrd.1975.111.3.325. [DOI] [PubMed] [Google Scholar]
- Heffernan J. F., Nunn A. J., Peto J., Fox W. Pulmonary tuberculosis in Scotland: a national sample survey and follow-up (1968-70). 1. The characteristics of the cases notified in 1968. Tubercle. 1975 Dec;56(4):253–267. doi: 10.1016/0041-3879(75)90083-5. [DOI] [PubMed] [Google Scholar]
- Heffernan J. F., Nunn A. J., Peto J., Fox W. Tuberculosis in Scotland: a national sample survey (1968-70). 2. A two-year follow-up of newly-diagnosed respiratory tuberculosis notified in 1968. Tubercle. 1976 Sep;57(3):161–175. doi: 10.1016/0041-3879(76)90025-8. [DOI] [PubMed] [Google Scholar]
- Leff A. R., Leff D. R., Brewin A. Tuberculosis chemotherapy practices in major metropolitan health departments in the United States. Am Rev Respir Dis. 1981 Feb;123(2):176–180. doi: 10.1164/arrd.1981.123.2.176. [DOI] [PubMed] [Google Scholar]